Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers Benecol, a cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain. It also provides Lissio HA for fine lines and wrinkles; Lissio Light for age spots; Lissio Pure for ageing and sensitive skin; Original Bioscalin to treat and prevent hair loss and scalp problems, as well as hair thinning and baldness; ZipClear to relieve symptoms associated with herpes simplex virus type 1; and Guma-eze, a soothing and cooling gel to ease gum soreness and discomfort caused by braces and dentures. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Procto-eze for anal irritation, including haemorrhoids conditions; and Ox-eze for aches and pains, and stiffness. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei vaginal atrophy, a topical cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Venture Life Group plc sells its products through a network of partners selling into the pharmacy channel. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolLON:VLG
CUSIPN/A
Phone+44-1344-742870
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-9.17%
Return on Equity-10.15%
Return on Assets-5.24%
Miscellaneous
EmployeesN/A
Outstanding Shares36,840,000
Market Cap£9.74 million
Venture Life Group (LON:VLG) Frequently Asked Questions
What is Venture Life Group's stock symbol?
Venture Life Group trades on the London Stock Exchange (LON) under the ticker symbol "VLG."
How often does Venture Life Group pay dividends? What is the dividend yield for Venture Life Group?
Venture Life Group declared a dividend on Thursday, March 22nd. Investors of record on Thursday, May 24th will be given a dividend of GBX 0.04 per share on Friday, June 22nd. This represents a dividend yield of 0.09%. The ex-dividend date is Thursday, May 24th. The official announcement can be viewed at this link. View Venture Life Group's Dividend History.
What price target have analysts set for VLG?
4 analysts have issued 1-year price objectives for Venture Life Group's shares. Their predictions range from GBX 100 to GBX 100. On average, they anticipate Venture Life Group's share price to reach GBX 100 in the next year. This suggests a possible upside of 96.1% from the stock's current price. View Analyst Price Targets for Venture Life Group.
What is the consensus analysts' recommendation for Venture Life Group?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Venture Life Group in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Venture Life Group.
Who are some of Venture Life Group's key competitors?
Some companies that are related to Venture Life Group include CV Sciences (CVSI), Aequus Pharmaceuticals (AQS), Shield Therapeutics (STX), EVIO (EVIO), Evgen Pharma (EVG), ESSA Pharma (EPI), Mountain High Acquisitions (MYHI), Lattice Biologics (LBL), Premier Biomedical (BIEI), Santo Mining (SANP), Choom (CHOOF), Correvio Pharma (CORV), Cosmos (COSM), Delta 9 Cannabis (NINE) and Green Organic Dutchman (TGOD).
Who are Venture Life Group's key executives?
Venture Life Group's management team includes the folowing people:
- Mr. Jeremy Anthony Philip Randall, CEO & Exec. Director (Age 53)
- Mr. Adrian Graham Crockett, CFO & Director (Age 50)
- Ms. Sharon Mary Collins, Commercial Director & Exec. Director (Age 43)
- Mr. Lodovico Gianluca Braguti, Manufacturing Director & Exec. Director
- Mr. Peter Shepherd, Group Financial Controller & Company Sec.
Has Venture Life Group been receiving favorable news coverage?
Media coverage about VLG stock has been trending positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Venture Life Group earned a media and rumor sentiment score of 0.27 on Accern's scale. They also assigned news articles about the company an impact score of 48.26 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Venture Life Group.
How do I buy shares of Venture Life Group?
Shares of VLG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Venture Life Group's stock price today?
One share of VLG stock can currently be purchased for approximately GBX 51.
How big of a company is Venture Life Group?
Venture Life Group has a market capitalization of £9.74 million.
How can I contact Venture Life Group?
Venture Life Group's mailing address is Venture House 2 Arlington Square, Downshire Way, BRACKNELL, RG12 1WA, United Kingdom. The company can be reached via phone at +44-1344-742870.
MarketBeat Community Rating for Venture Life Group (LON VLG)
MarketBeat's community ratings are surveys of what our community members think about Venture Life Group and other stocks. Vote "Outperform" if you believe VLG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VLG will underperform the S&P 500 over the long term. You may vote once every thirty days.
